{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:10:06Z","timestamp":1793067006972,"version":"4.5.0"},"reference-count":58,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dement. neuropsychol."],"abstract":"<jats:p>ABSTRACT Although the most prominent symptoms of Parkinson\u2019s disease (PD) are those impacting movement, cognitive dysfunction is prevalent and often presents early in the disease process. Individuals with cognitive symptoms of PD often complete cognitive screening, making it important to identify factors associated with cognitive screening performance to ensure prompt and accurate detection of cognitive impairments.  Objective: Despite a body of research examining relationships between motor symptoms and cognitive dysfunction in PD, no prior study has undertaken a systematic review of the magnitude of the relationship between motor symptoms and cognitive screening performance in PD.  Methods: This study was a systematic review and meta-analysis of the relationship between cognitive screening performance, as assessed by the Montreal Cognitive Assessment (MoCA), and motor symptoms of PD. After the systematic screening, 20 studies were included, and meta-regressions using mixed-effects models were conducted.  Results: Motor symptoms across included studies were relatively mild, but average MoCA scores were at the established cutoff for risk of dementia in PD. The average disease duration was 5 years. Consistent with hypotheses, more severe motor symptoms were associated with lower MoCA scores (r=-0.22 (95%CI -0.29 to -0.16), p&lt;0.001), indicating worse cognitive functioning.  Conclusion: The results indicate a significant negative correlation between MoCA performance and motor symptoms of PD. Average MoCA scores captured early disease-stage cognitive impairment when motor symptoms remained relatively mild. Serial screening for cognitive impairment beginning early in the disease course may be of benefit to ensure that cognitive dysfunction is detected as it arises.<\/jats:p>","DOI":"10.1590\/1980-5764-dn-2023-0102","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T12:13:22Z","timestamp":1725279202000},"source":"Crossref","is-referenced-by-count":4,"title":["Associations between cognitive screening performance and motor symptoms in Parkinson\u2019s disease:a systematic review and meta-analysis"],"prefix":"10.1590","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1139-8670","authenticated-orcid":false,"given":"Karlee","family":"Patrick","sequence":"first","affiliation":[{"name":"Kent State University,  USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1840-8189","authenticated-orcid":false,"given":"Elizabeth","family":"Cousins","sequence":"additional","affiliation":[{"name":"Kent State University,  USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4314-1252","authenticated-orcid":false,"given":"Mary Beth","family":"Spitznagel","sequence":"additional","affiliation":[{"name":"Kent State University,  USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref1","series-title":"J Neural Transm","first-page":"563","volume-title":"Cognition, motor symptoms, and glycolipid metabolism in Parkinson\u2019s disease with depressive symptoms","volume":"129","author":"Yao C","year":"2022"},{"key":"ref2","series-title":"J Neural Transm","first-page":"1397","volume-title":"The pathobiological basis of depression in Parkinson disease: challenges and outlooks","volume":"129","author":"Jellinger KA.","year":"2022"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.neubiorev.2016.07.010","article-title":"Motor symptoms in Parkinson\u2019s disease: a unified framework","volume":"68","author":"Moustafa AA","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"issue":"8","key":"ref4","first-page":"504","article-title":"Parkinson\u2019s disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis.","volume":"40","author":"DeMaagd G","year":"2015","journal-title":"P T"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"e0159318","DOI":"10.1371\/journal.pone.0159318","article-title":"Screening for cognitive impairment in Parkinson\u2019s disease: improving the diagnostic utility of the MoCA through subtest weighting","volume":"11","author":"Fengler S","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland D","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"ref7","first-page":"71","article-title":"Rational pharmacological approaches for cognitive dysfunction and depression in Parkinson\u2019s disease","volume":"6","author":"Sandoval-Rinc\u00f3n M","year":"2015","journal-title":"Front Neurol"},{"issue":"6","key":"ref8","first-page":"441","article-title":"Mild cognitive impairment in Parkinson\u2019s disease","volume":"102","author":"Goldman JG","year":"2011","journal-title":"Minerva Med"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3233\/JPD-212581","article-title":"Which neuropsychological tests? Predicting cognitive decline and dementia in Parkinson\u2019s disease in the ICICLE-PD cohort","volume":"11","author":"Lawson RA","year":"2021","journal-title":"J Parkinsons Dis"},{"key":"ref10","first-page":"2076942","article-title":"Cognition deficits in Parkinson\u2019s disease: mechanisms and treatment","volume":"2020","author":"Fang C","year":"2020","journal-title":"Parkinsons Dis"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"e00719","DOI":"10.1002\/brb3.719","article-title":"Associations between cognitive impairment and motor dysfunction in Parkinson\u2019s disease","volume":"7","author":"Wang YX","year":"2017","journal-title":"Brain Behav"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1037\/neu0000583","article-title":"Depressive symptoms precede cognitive impairment in de novo Parkinson\u2019s disease patients: analysis of the PPMI cohort","volume":"33","author":"Jones JD","year":"2019","journal-title":"Neuropsychology"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1532-5415.2008.02096.x","article-title":"Montreal cognitive assessment performance in patients with Parkinson\u2019s disease with \u201cnormal\u201d global cognition according to mini-mental state examination score","volume":"57","author":"Nazem S","year":"2009","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.2049-4173.2013.00032.x","article-title":"The Montreal Cognitive Assessment and neurobehavioral cognitive status examination are useful for screening mild cognitive impairment in Japanese patients with Parkinson\u2019s disease","volume":"1","author":"Murakami H","year":"2013","journal-title":"Neurol Clin Neurosci"},{"issue":"s1","key":"ref15","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.3233\/JPD-202135","article-title":"Young onset Parkinson\u2019s disease: a modern and tailored approach","volume":"10","author":"Post B","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"776847","DOI":"10.3389\/fpubh.2021.776847","article-title":"Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s disease in 204 countries\/territories from 1990 to 2019","volume":"9","author":"Ou Z","year":"2021","journal-title":"Front Public Health"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0035-1555115","article-title":"The impact of age on cognition","volume":"36","author":"Murman DL.","year":"2015","journal-title":"Semin Hear"},{"key":"ref18","series-title":"Behav Sci","first-page":"74","volume-title":"Cognitive impairment in Parkinson\u2019s disease: epidemiology, clinical profile, protective and risk factors","volume":"11","author":"Gonzalez-Latapi P","year":"2021"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12264-012-1050-z","article-title":"Progression of motor symptoms in Parkinson\u2019s disease","volume":"28","author":"Xia R","year":"2012","journal-title":"Neurosci Bull"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"791532","DOI":"10.3389\/fnagi.2021.791532","article-title":"Sex differences in brain and cognition in de novo Parkinson\u2019s disease","volume":"13","author":"Oltra J","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"19","key":"ref21","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/WNL.0b013e3181fc29c9","article-title":"The MoCA: well-suited screen for cognitive impairment in Parkinson disease","volume":"75","author":"Dalrymple-Alford JC","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"11461","DOI":"10.1038\/s41598-022-15630-8","article-title":"Associations of cognitive dysfunction with motor and non-motor symptoms in patients with de novo Parkinson\u2019s disease","volume":"12","author":"Kwon KY","year":"2022","journal-title":"Sci Rep"},{"issue":"71","key":"ref23","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine ZS","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"e011458","DOI":"10.1136\/bmjopen-2016-011458","article-title":"Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)","volume":"6","author":"Downes MJ","year":"2016","journal-title":"BMJ Open"},{"key":"ref26","series-title":"A hands-on guide","doi-asserted-by":"crossref","DOI":"10.1201\/9781003107347","volume-title":"Doing meta-analysis with R","author":"Harrer M","year":"2021"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi S.","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/9780470712184.ch9","article-title":"Analysing data and undertaking meta-analyses. In:","author":"Deeks JJ","year":"2008","journal-title":"Cochrane Handbook for Systematic Reviews of Interventions. Wiley Online Library;"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","article-title":"Assessing heterogeneity in meta-analysis: Q statistic or I2 index?","volume":"11","author":"Huedo-Medina TB","year":"2006","journal-title":"Psychol Methods"},{"key":"ref30","series-title":"J Neural Transm","first-page":"687","volume-title":"Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson\u2019s disease patients","volume":"130","author":"Aiello EN","year":"2023"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1038\/s41598-021-84243-4","article-title":"Donepezil for mild cognitive impairment in Parkinson\u2019s disease","volume":"11","author":"Baik K","year":"2021","journal-title":"Sci Rep"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jocn.2020.03.015","article-title":"Domain specific cognitive impairment in Parkinson\u2019s patients with mild cognitive impairment","volume":"75","author":"Chaudhary S","year":"2020","journal-title":"J Clin Neurosci"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1080\/13803395.2018.1485880","article-title":"Computerized testing in Parkinson\u2019s disease: Performance deficits in relation to standard clinical measures","volume":"40","author":"Flannery SL","year":"2018","journal-title":"J Clin Exp Neuropsychol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.parkreldis.2017.02.008","article-title":"Domain-specific accuracy of the Montreal Cognitive Assessment subsections in Parkinson\u2019s disease","volume":"38","author":"Hendershott TR","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"issue":"21","key":"ref35","doi-asserted-by":"crossref","first-page":"17381","DOI":"10.1212\/WNL.0b013e3181c34b47","article-title":"Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease","volume":"73","author":"Hoops S","year":"2009","journal-title":"Neurology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1142558","DOI":"10.3389\/fnagi.2023.1142558","article-title":"Predictors of cognitive impairment in newly diagnosed Parkinson\u2019s disease with normal cognition at baseline: a 5-year cohort study","volume":"15","author":"Chen J","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fnagi.2018.00090","article-title":"Pupillary response to cognitive demand in Parkinson\u2019s disease: a pilot study","volume":"10","author":"Kahya M","year":"2018","journal-title":"Front Aging Neurosc"},{"issue":"11","key":"ref38","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.5664\/jcsm.3148","article-title":"Effects of sleep disorders on the non-motor symptoms of Parkinson disease","volume":"9","author":"Neikrug AB","year":"2013","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1176\/appi.neuropsych.17090177","article-title":"Anxiety independently contributes to severity of freezing of gait in people with Parkinson\u2019s disease","volume":"31","author":"Pimenta M","year":"2019","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"e0257966","DOI":"10.1371\/journal.pone.0257966","article-title":"Pain coping strategies and their association with quality of life in people with Parkinson\u2019s disease: a cross-sectional study","volume":"16","author":"Prell T","year":"2021","journal-title":"PLoS One"},{"issue":"10","key":"ref41","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/mds.25124","article-title":"The pill questionnaire in a nondemented Parkinson\u2019s disease population","volume":"27","author":"Reginold W","year":"2012","journal-title":"Mov Disord"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"709998","DOI":"10.3389\/fnagi.2021.709998","article-title":"Abnormal neural activity in different frequency bands in parkinson\u2019s disease with mild cognitive impairment","volume":"13","author":"Rong S","year":"2021","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1089\/brain.2020.0985","article-title":"Brain networks and cognitive impairment in Parkinson\u2019s disease","volume":"12","author":"Rucco R","year":"2022","journal-title":"Brain Connect"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.parkreldis.2018.06.001","article-title":"A detailed clinical study of pain in 1957 participants with early\/moderate Parkinson\u2019s disease","volume":"56","author":"Silverdale MA","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1055\/s-0043-1761294","article-title":"Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson\u2019s disease","volume":"81","author":"Soares NM","year":"2023","journal-title":"Arq Neuropsiquiatr"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fnagi.2020.00050","article-title":"Goalkeeper game: a new assessment tool for prediction of gait performance under complex condition in people with Parkinson\u2019s disease","volume":"12","author":"Stern RB","year":"2020","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.15619\/NZJP\/49.1.06","article-title":"Self-reported depression and anxiety are correlated with functional disability in Parkinson\u2019s disease","volume":"49","author":"Still A","year":"2023","journal-title":"New Zealand Journal of Physiotherapy"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/aian.AIAN_357_18","article-title":"Functional outcome of bilateral subthalamic nucleus-deep brain stimulation in advanced Parkinson\u2019s disease patients: a prospective study","volume":"23","author":"Tandra S","year":"2020","journal-title":"Ann Indian Acad Neurol"},{"issue":"4","key":"ref49","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/jnnp-2019-322042","article-title":"Brain iron deposition is linked with cognitive severity in Parkinson\u2019s disease","volume":"91","author":"Thomas GEC","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"15","key":"ref50","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz CG","year":"2008","journal-title":"Mov Disord"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.parkreldis.2014.10.026","article-title":"Parkinson\u2019s disease severity levels and MDS-Unified Parkinson\u2019s Disease Rating Scale","volume":"21","author":"Mart\u00ednez-Mart\u00edn P","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"ref52","first-page":"91","article-title":"Prediction of cognitive progression in Parkinson\u2019s disease using three cognitive screening measures","volume":"1","author":"Kim HM","year":"2019","journal-title":"Clin Park Relat Disord"},{"issue":"4","key":"ref53","doi-asserted-by":"crossref","first-page":"e0123231","DOI":"10.1371\/journal.pone.0123231","article-title":"Relationship between motor symptoms, cognition, and demographic characteristics in treated mild\/moderate Parkinson\u2019s disease","volume":"10","author":"Schneider JS","year":"2015","journal-title":"PLoS One"},{"key":"ref54","series-title":"J Neural Transm","first-page":"431","volume-title":"MMSE and MoCA in Parkinson\u2019s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study","volume":"123","author":"Biundo R","year":"2016"},{"issue":"1-2","key":"ref55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000447533","article-title":"Mild cognitive impairment in patients with early-onset Parkinson\u2019s disease","volume":"42","author":"Seubert-Ravelo AN","year":"2016","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2013.08.010","article-title":"Cognitive reserve in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"20","author":"Hindle JV","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"ref57","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.3390\/ijms22073781","article-title":"Polymorphisms of dopamine receptor genes and Parkinson\u2019s disease: clinical relevance and future perspectives","volume":"22","author":"Magistrelli L","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref58","first-page":"8610285","article-title":"Cognitive impairment in genetic Parkinson\u2019s disease","volume":"2021","author":"Planas-Ballv\u00e9 A","year":"2021","journal-title":"Parkinsons Dis"}],"container-title":["Dementia &amp; Neuropsychologia"],"original-title":["Associa\u00e7\u00f5es entre desempenho em triagem cognitiva e sintomas motores na doen\u00e7a de Parkinson: uma revis\u00e3o sistem\u00e1tica e meta-an\u00e1lise"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S1980-57642024000100213&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T13:27:34Z","timestamp":1738848454000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1980-57642024000100213&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":58,"alternative-id":["S1980-57642024000100213"],"URL":"https:\/\/doi.org\/10.1590\/1980-5764-dn-2023-0102","relation":{},"ISSN":["1980-5764"],"issn-type":[{"value":"1980-5764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e20230102"}}